Patents by Inventor Olivier Finance

Olivier Finance has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
    Patent number: 6969723
    Abstract: Compounds of general formula (I), wherein R4 and R5 stand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched C1-4 alkyl group, straight or branched C1-4 alkoxy group, hydroxy group or halogen atom; are strong adenosine A3 receptor ligands preferably antagonists.
    Type: Grant
    Filed: May 29, 2002
    Date of Patent: November 29, 2005
    Assignee: Sanofi - Aventis
    Inventors: Peter Arányi, László Balázs, Mária Balogh, Imre Bata, Sándor Bátori, Lajos T. Nagy, Geza Tímári, Kinga Boér, Olivier Finance, Zoltán Kapui, Endre Mikus, Zsuzsanna Szamosvölgyi, Gábor Szeleczky, Katalin Urbán-Szabó
  • Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
    Publication number: 20040186133
    Abstract: Compounds of general formula (I), wherein R4 and R5 stand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched C1-4 alkyl group, straight or branched C1-4 alkoxy group, hydroxy group or halogen atom; are strong adenosine A3 receptor ligands preferably antagonists.
    Type: Application
    Filed: May 13, 2004
    Publication date: September 23, 2004
    Inventors: Peter Aranyl, Laszlo Balazs, Maria Balogh, Imre Bata, Sandor Batori, Lajos T. Nagy, Geza Timari, Kinga Boer, Olivier Finance, Zoltan Kapul, Endre Mikus, Zsuzsanna Szamosvolgyi, Gabor Szeleczky, Katalin Urban-Szabo